Signaling Pathways
-
A3347 Dabrafenib Mesylate (GSK-2118436)Target: RafSummary: Inhibitor of BRAF(V600) mutants
-
A3352 Daun022 CitationSummary: Cell viability inhibitor,DNA synthisis inhibitor
-
A3358 DeltarasinTarget: Phosphodiesterases (PDEs)Summary: KRAS-PDEδ interaction inhibitor
-
A3368 DMAT2 CitationTarget: Pim|CK2|HIPK2|HIPK3Summary: CK2 inhibitor,potent and selective
-
A3374 DronedaroneTarget: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channelSummary: CYP3A4 and 2D6 inhibitor,moderate
-
A3381 EdoxabanTarget: Factor XaSummary: Factor Xa inhibitor
-
A3384 ElacridarTarget: P-glycoprotein (P-gp)Summary: BCRP inhibitor
-
A3389 EMD6386834 CitationTarget: SGKSummary: SGK1 inhibitor
-
A3392 EmodinTarget: CK2Summary: Naturally occurring anthraquinone,antiproliferative
-
A3394 Epothilone DTarget: Microtubule/TubulinSummary: Natural polyketide compound